Supernus Pharmaceuticals' Unit Acquisition

Supernus Pharmaceuticals raised a round of funding on December 13, 2005. Investors include Supernus Pharmaceuticals.

Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. The company is developi…

Articles about Supernus Pharmaceuticals' Unit Acquisition: